Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Heming

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
BMJ Open|April 27, 2022
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trialVincent Labbe, Damien Contou, Nicholas Heming, et al.
Critical Care (London, England)|February 22, 2022
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trialAntoine Monsel, Caroline Hauw-Berlemont, Miryam Mebarki, et al.
JAMA Internal Medicine|March 22, 2023
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical TrialVincent Labbé, Damien Contou, Nicholas Heming, et al.
Stem Cell Research & Therapy|April 18, 2024
Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of lifeAlexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, et al.
Annals of Intensive Care|July 15, 2025
Expert consensus‑based clinical practice guidelines for nutritional support in the intensive care unit: the French Intensive Care Society (SRLF) and the French-Speaking Group of Pediatric Emergency Physicians and Intensivists (GFRUP)Jean Reignier, Benedicte Gaillard-Le Roux, Pierre François Dequin, et al.
Infectious Diseases and Therapy|January 6, 2026
Clinical Phenotypes of Critically Ill Patients with COVID-19 Infected with Omicron: A Nationwide Prospective Cohort StudyEtienne Audureau, Pierre Bay, Sébastien Préau, et al.
BMJ Open|April 1, 2025
Risk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trialVincent Labbé, Cyrielle Desnos, Sebastien Preau, et al.
Intensive Care Medicine Experimental|August 6, 2023
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort studyNicolas de Prost, Etienne Audureau, Sébastien Préau, et al.
Annals of Intensive Care|October 22, 2025
Neuromuscular blockade and their monitoring in the intensive care unit: a multicenter observational prospective studyBertrand Hermann, Guillaume Decormeille, Tiphanie Gobé, et al.
The Lancet. Respiratory Medicine|February 4, 2024
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trialNicholas Heming, Alain Renault, Emmanuelle Kuperminc, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMJ Open|April 27, 2022
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trialVincent Labbe, Damien Contou, Nicholas Heming, et al.
Critical Care (London, England)|February 22, 2022
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trialAntoine Monsel, Caroline Hauw-Berlemont, Miryam Mebarki, et al.
JAMA Internal Medicine|March 22, 2023
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical TrialVincent Labbé, Damien Contou, Nicholas Heming, et al.
Stem Cell Research & Therapy|April 18, 2024
Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of lifeAlexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, et al.
Annals of Intensive Care|July 15, 2025
Expert consensus‑based clinical practice guidelines for nutritional support in the intensive care unit: the French Intensive Care Society (SRLF) and the French-Speaking Group of Pediatric Emergency Physicians and Intensivists (GFRUP)Jean Reignier, Benedicte Gaillard-Le Roux, Pierre François Dequin, et al.
Infectious Diseases and Therapy|January 6, 2026
Clinical Phenotypes of Critically Ill Patients with COVID-19 Infected with Omicron: A Nationwide Prospective Cohort StudyEtienne Audureau, Pierre Bay, Sébastien Préau, et al.
BMJ Open|April 1, 2025
Risk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trialVincent Labbé, Cyrielle Desnos, Sebastien Preau, et al.
Intensive Care Medicine Experimental|August 6, 2023
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort studyNicolas de Prost, Etienne Audureau, Sébastien Préau, et al.
Annals of Intensive Care|October 22, 2025
Neuromuscular blockade and their monitoring in the intensive care unit: a multicenter observational prospective studyBertrand Hermann, Guillaume Decormeille, Tiphanie Gobé, et al.
The Lancet. Respiratory Medicine|February 4, 2024
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trialNicholas Heming, Alain Renault, Emmanuelle Kuperminc, et al.
Pageof 8